Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2019; 9(26):8196-8205. doi:10.7150/thno.36455 This issue Cite

Research Paper

Optogenetic control of mesenchymal cell fate towards precise bone regeneration

Weicai Wang, Delan Huang, Jianhan Ren, Runze Li, Zhicai Feng, Chenyu Guan, Baicheng Bao, Bin Cai, Junqi Ling, Chen Zhou✉

1. Guanghua School of Stomatology, Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, 56 Lingyuanxi Road, Guangzhou 510055, China.

✉ Corresponding author: zhouch46sysu.edu.cn

Citation:
Wang W, Huang D, Ren J, Li R, Feng Z, Guan C, Bao B, Cai B, Ling J, Zhou C. Optogenetic control of mesenchymal cell fate towards precise bone regeneration. Theranostics 2019; 9(26):8196-8205. doi:10.7150/thno.36455. https://www.thno.org/v09p8196.htm
Other styles

File import instruction

Abstract

Graphic abstract

Rationale: Spatial-temporal control of cell fate in vivo is of great importance for regenerative medicine. Currently, there remain no practical strategies to tune cell-fate spatial-temporally. Optogenetics is a biological technique that widely used to control cell activity in genetically defined neurons in a spatiotemporal-specific manner by light. In this study, optogenetics was repurposed for precise bone tissue regeneration.

Methods: Lhx8 and BMP2 genes, which are considered as the master genes for mesenchymal stem cell proliferation and differentiation respectively, were recombined into a customized optogenetic control system. In the system, Lhx8 was constitutively expressed, while BMP2 together with shLhx8 expression was driven by blue light.

Results: As expected, blue light induced BMP2 expression and inactivated Lhx8 expression in cells infected with the optogenetic control system. Optogenetic control of BMP2 and Lhx8 expression inversely regulates MSC fate in vitro. By animal study, we found that blue light could fine-tune the regeneration in vivo. Blue light illumination significantly promotes bone regeneration when the scaffold was loaded with MSCs infected with adeno-Lhx8, GI-Gal4DBD, LOV-VP16, and BMP2-shLhx8.

Conclusions: Together, our study revealed that optogenetic control of the master genes for mesenchymal stem cell proliferation and differentiation would be such a candidate strategy for precise regenerative medicine.

Keywords: Optogenetics, bone tissue regeneration, gene expression control, proliferation and differentiation

Citation styles

APA
Wang, W., Huang, D., Ren, J., Li, R., Feng, Z., Guan, C., Bao, B., Cai, B., Ling, J., Zhou, C. (2019). Optogenetic control of mesenchymal cell fate towards precise bone regeneration. Theranostics, 9(26), 8196-8205. https://doi.org/10.7150/thno.36455.

ACS
Wang, W.; Huang, D.; Ren, J.; Li, R.; Feng, Z.; Guan, C.; Bao, B.; Cai, B.; Ling, J.; Zhou, C. Optogenetic control of mesenchymal cell fate towards precise bone regeneration. Theranostics 2019, 9 (26), 8196-8205. DOI: 10.7150/thno.36455.

NLM
Wang W, Huang D, Ren J, Li R, Feng Z, Guan C, Bao B, Cai B, Ling J, Zhou C. Optogenetic control of mesenchymal cell fate towards precise bone regeneration. Theranostics 2019; 9(26):8196-8205. doi:10.7150/thno.36455. https://www.thno.org/v09p8196.htm

CSE
Wang W, Huang D, Ren J, Li R, Feng Z, Guan C, Bao B, Cai B, Ling J, Zhou C. 2019. Optogenetic control of mesenchymal cell fate towards precise bone regeneration. Theranostics. 9(26):8196-8205.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use